Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common shares, US$0.001 nominal value per share
-
Shares outstanding
-
1.85B
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
16.6M
-
Shares change
-
-458K
-
Total reported value, excl. options
-
$764M
-
Value change
-
-$20.2M
-
Put/Call ratio
-
43
-
Number of buys
-
32
-
Number of sells
-
-27
-
Price
-
$46.07
Significant Holders of VEON Ltd. - Common shares, US$0.001 nominal value per share (VEON) as of Q2 2025
82 filings reported holding VEON - VEON Ltd. - Common shares, US$0.001 nominal value per share as of Q2 2025.
VEON Ltd. - Common shares, US$0.001 nominal value per share (VEON) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.6M shares
of 1.85B outstanding shares and own 0.9% of the company stock.
Largest 10 shareholders include Lingotto Investment Management LLP (5.96M shares), SHAH CAPITAL MANAGEMENT (4.92M shares), Helikon Investments Ltd (1.46M shares), Solus Alternative Asset Management LP (856K shares), MORGAN STANLEY (648K shares), WELLINGTON MANAGEMENT GROUP LLP (637K shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (501K shares), TWO SIGMA INVESTMENTS, LP (210K shares), GABELLI FUNDS LLC (129K shares), and Russell Investments Group, Ltd. (122K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.